GLOBAL HEADQUATERS
C&D Incubation Office
KHIDI provides physical and virtual office space at CIC Cambridge to support Korean bio-health companies seeking to establish and expand their presence in the U.S. market.
Through the C&D(Connect and Development) Incubation Office program, participating companies receive comprehensive support for global market entry, including business development and commercialization consulting, access to local industry events, and opportunities to build networks and partnerships within the U.S. innovation ecosystem.
As of 2026, 45 companies are participating in the program, strengthening their foundation for successful entry into the U.S. market.
1ST Biotherapeutics Inc.
Innovative Therapeutics Development for Neurodegenerative Diseases and Cancer
Abion Inc.
Targeted Lung Cancer Therapeutics and Inhalable Broad-Spectrum Antiviral Agents
AITRICS Co., Ltd.
AI-Powered Medical Device Software for Monitoring Hospitalized Patients and Predicting Acute Clinical Deterioration
Apollon Inc.
Development of a Miniaturized, Needle-Free, Non-Invasive Continuous Glucose Monitoring Medical Device Using Raman Scattering-Based Optical Technology
Autotelic Bio Inc.
Fixed-Dose Combination Therapy for Hypertension and Diabetes, and RNA-Based Drug Development
Biotoxtech Co., Ltd.
Nonclinical Safety Assessment, Efficacy and Pharmacological Evaluation, and Drug Development Consulting Services
C&R Research, Inc.
Regulatory Strategy Consulting and Clinical Trial Execution for Pharmaceutical Development
CG Bio Inc.
Recombinant Human Bone Growth Factor-Based Bone Graft Substitute for Spinal Fusion
Chong Kun Dang
Manufacturing and Sales of Prescription Drugs, Over-the-Counter Medicines, and Quasi-Drugs, Including Treatments for Hypertension, Hyperlipidemia, and Diabetes
N/A
CJ CheilJedang Corporation
Innovative Drug Development and Manufacturing Services
N/A
CUROGEN Technology
Development of First-in-Class and Best-in-Class Therapeutics for Autoimmune and Intractable Diseases
Daewoong Pharmaceutical Co., Ltd.
Novel Anticancer Drug Candidates and Neurodegenerative Disease Therapeutics (Parkinson’s Disease)
Dong-A ST Co., Ltd.
R&D of Innovative Immunology and Oncology Drugs, Globally Branded Novel Drugs, DDS-Based Improved Drugs, and Biopharmaceuticals
N/A
Elisigen Inc.
Gene Therapy for Wet Age-Related Macular Degeneration (Wet AMD)
HLB Co., Ltd.
Therapeutics for Intractable, Severe, and Rare Diseases; Implantable Medical Devices; Innovative Platforms; Nonclinical Services; and Diagnostic Systems
HoneyNaps Co., Ltd.
AI-Powered Medical Software for Sleep Data Analysis and Interpretation
Huons USA
Injectable Pharmaceuticals, Artificial Tear Eye Drops, and Dental Anesthetics
IMeditech Inc.
Portable Precision Nanofiber Spinning Systems, Advanced Nanofiber Wound Dressings for Tissue Regeneration, and Anti-Adhesion Barriers
IMGT Co., Ltd.
High-Intensity Focused Ultrasound (HIFU) Surgical System
ImmunoForge, Co., Ltd.
Drug Development Technologies for Rare and Intractable Diseases and Novel Anticancer Therapeutics
Intek Scientific Inc.
Innovative Therapeutics Development for Neurodegenerative Diseases and Cancer
N/A
JW Theriac
Innovative Therapeutics Development for Neurodegenerative Diseases and Cancer
KadisBio, Inc.
Cell Therapies for Cardiovascular Diseases Using Induced Pluripotent Stem Cell (iPSC) Differentiation and Direct Reprogramming Technologies
Keyprime research Co., Ltd.
Nonclinical Safety and Efficacy Evaluation in Non-Human Primates
LOTTE BIOLOGICS
Biopharmaceutical CDMO Services (Contract Development and Manufacturing of Animal Cell-Based Biologics)
N/A
MEDI-IoT
PBM-Based Wearable Medical Device for Ocular Diseases
MediMabBio Inc.
Cytokine-Antibody Fusion Platform Technology and Novel Therapeutics for Immune and Inflammatory Diseases and Cancer Immunotherapy
Medipixel, Inc.
AI-Based Cardiovascular Imaging Analysis Solutions
MedySapiens, Inc.
AI-Powered Genomic Analysis and Diagnostic Support Software
Mepsgen Co., Ltd.
Biopharmaceutical Development and Research Services Using Organ-on-a-Chip Platform Technology
NEUROPHET Inc.
AI-Powered Medical Analysis Solutions Specialized in Brain Diseases, Including Alzheimer’s Disease
NEX-I, Inc.
Therapeutic Candidate for Metastatic Non-Small Cell Lung Cancer Using an Antibody Targeting the Immunotherapy Resistance Factor ONCOKINE-1
ORGANOID SCIENCES Ltd.
Organoid-Based Regenerative Therapeutics and Drug Efficacy Evaluation Platform
Portrai Inc.
Spatial Intelligence-Based Precision Medicine TechBio Infrastructure Platform Company
PROTEINA
Single-Molecule Protein Interaction Detection (SPID) Platform
Space Liin Tech
Microgravity-Based Space Protein Crystallization Services
Txinno Bioscience Inc.
Novel Anticancer Therapeutics Targeting Innate Immune Checkpoints
VORONOI Inc.
Innovative Therapeutics Development for Neurodegenerative Diseases and Cancer
VSPharmTech
Development of Radiation Therapy Enhancers
WittGen Inc.
Large-Scale Single-Cell and GenAI-Based Virtual Patient Profiling Platform to Accelerate Precision Drug Development and Clinical Success
Yuhan USA
Therapeutics for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
ZEON AI Inc.
AI Platform for Clinical Trial Patient Selection and Anticancer Drug Response Prediction